Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Invested Capital (2018 - 2025)

TransMedics (TMDX) has 7 years of Return on Invested Capital data on record, last reported at 0.2% in Q1 2025.

  • For Q1 2025, Return on Invested Capital rose 30.0% year-over-year to 0.2%; the TTM value through Mar 2025 reached 0.2%, up 30.0%, while the annual FY2025 figure was 0.11%, 5.0% up from the prior year.
  • Return on Invested Capital reached 0.2% in Q1 2025 per TMDX's latest filing, up from 0.05% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.28% in Q3 2023 and bottomed at 1.34% in Q4 2023.
  • Average Return on Invested Capital over 5 years is 0.25%, with a median of 0.13% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: tumbled -122bps in 2023, then skyrocketed 140bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.54% in 2021, then soared by 77bps to 0.12% in 2022, then tumbled by -987bps to 1.34% in 2023, then soared by 104bps to 0.05% in 2024, then soared by 263bps to 0.2% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.2% in Q1 2025, 0.05% in Q4 2024, and 0.16% in Q3 2024.